Muse Bio (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- March 01, 2017
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $23,000,000
Company Info
- Founders
- Kevin Ness
- Company Description
- Muse bio is enabling a new era of genome engineering that will transform our understanding of biology. Muse bio delivers power to researchers and production scientists in the field of genome engineering and synthetic biology through the combination of a powerful computer aided forward design software package, a proprietary benchtop biofoundry, and custom reagents. Its next-generation, CRISPR-based ForgeCraft technology dramatically accelerates genome engineering.
- Market
- Genome Engineering and Synthetic Biology
- Location
- Boulder, Colorado, USA
- Coinvestors
- Foresite Capital, NanoDimension, Paladin Capital Group, Spruce-MLS, Venrock